“Commenting on the success, BIO-key CEO Mike DePasquale asserted that his company has seen ‘particularly strong sales traction in healthcare, expanding beyond our initial success with large hospital customers.'”
In a statement, BIO-key said the clients spanned “hospitals, eye care centers, medical device manufacturers, medical labs and group practices,” and said the clients are using its biometric fingerprint scanning technologies to improve efficiency, improve security, and comply with regulations.
Commenting on the success, BIO-key CEO Mike DePasquale asserted that his company has seen “particularly strong sales traction in healthcare, expanding beyond our initial success with large hospital customers.” DePasquale added that the demand “is being driven by regulatory compliance and supported by the workplace convenience” of biometric solutions.
The Q2 success appears to be at least partially the result of a strong market focus on BIO-key’s part, with the company having announced in February that multiple partners would showcase its technology at this year’s HIMSS conference.
The healthcare market success also hints at another strong quarter in terms of revenues for BIO-key after the company reported a significant increase in Q1.
July 20th, 2017 – by Alex Perala